They made Group EBITDA of $2.2m in July, as shared in the trading update.
July not exactly a big month, with no Easter, Christmas, etc so we can assume growth from there.
We know the transaction value in August exceeded July.
12 x July's EBITDA gives you $26.4m in EBITDA for the year, which is just over the mid-point of guidance ($23m - $29m).
With transaction growth during the year across terminals and online, with Christmas still to come, I can see them exceeding guidance.
Price target by end of year $2.50 for me.
This bid has just made the market wake up again as operating leverage kicks in.
- Forums
- ASX - By Stock
- TYR
- Ann: Tyro Rejects Non-Binding Indicative Proposal
TYR
tyro payments limited
Add to My Watchlist
1.12%
!
88.0¢

Ann: Tyro Rejects Non-Binding Indicative Proposal, page-35
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
88.0¢ |
Change
-0.010(1.12%) |
Mkt cap ! $464.9M |
Open | High | Low | Value | Volume |
89.0¢ | 89.5¢ | 86.8¢ | $759.2K | 863.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 47232 | 87.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
89.0¢ | 39712 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 33000 | 0.865 |
1 | 44000 | 0.860 |
1 | 10000 | 0.850 |
2 | 7322 | 0.835 |
2 | 20000 | 0.830 |
Price($) | Vol. | No. |
---|---|---|
0.890 | 5833 | 3 |
0.895 | 4327 | 1 |
0.900 | 34646 | 6 |
0.910 | 15200 | 4 |
0.920 | 73569 | 5 |
Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
Featured News
TYR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online